- Bedoelde u
- virus vaccines
Zoekresultaten - 265 results
Oncolytic Viruses: An Inventory of Shedding Data from Clinical Trials and Elements for the Environmental Risk Assessment.
replication-defective viral vectors commonly used in gene therapy or vaccination. To our knowledge, this article presents the most extensive and up-to-date review of shedding data reported with OV employed in clinics. ...
Surveillance des infections à influenza. Rapport épidémiologique saison 2019-2020
infectious diseases Étude des soins de santé Gezondheidszorgonderzoek Health services research Maladies virales Virale ziekten Viral diseases Manuscript versions: File: Version: Published Full text access: ...
Humoral and cellular immune correlates of protection against COVID-19 in kidney transplant recipients.
J Transplant, Volume 23, Issue 5 (2023) Keywords: Antibodies, Neutralizing Antibodies, Viral BNT162 Vaccine Breakthrough Infections Cohort Studies COVID-19 Humans Immunoglobulin G Interferon-gamma Kidney ...
Third dose of COVID-19 mRNA vaccine closes the gap in immune response between naïve nursing home residents and healthy adults.
Antibodies, Viral BNT162 Vaccine Breakthrough Infections COVID-19 COVID-19 Vaccines Humans Immunity nursing homes Population Groups RNA, Messenger SARS-CoV-2 Abstract: BACKGROUND: Nursing home residents, ...
Homologous versus heterologous prime-boost COVID-19 vaccination: impact on clinical severity of Omicron among hospitalized COVID-19 patients in Belgium
confirmed by whole genome sequencing and vaccinated with a homologous (mRNA for prime/mRNA for boost) or heterologous (viral vector for prime/mRNA for boost) prime-boost vaccination schedule were included in ...
Development and Validation of a New DIVA Real-Time PCR Allowing to Differentiate Wild-Type Lumpy Skin Disease Virus Strains, Including the Asian Recombinant Strains, from Neethling-Based Vaccine Strains.
Cattle Lumpy skin disease Lumpy skin disease virus Real-Time Polymerase Chain Reaction Vaccines, Attenuated Viral Vaccines Abstract: The current epidemic in Asia, driven by LSDV recombinants, poses ...
Homologous and Heterologous Prime-Boost Vaccination: Impact on Clinical Severity of SARS-CoV-2 Omicron Infection among Hospitalized COVID-19 Patients in Belgium
investigated effectiveness of (1) mRNA booster vaccination versus primary vaccination only and (2) heterologous (viral vector-mRNA) versus homologous (mRNA-mRNA) prime-boost vaccination against severe outcomes ...
Duration of Immunity Induced after Vaccination of Cattle with a Live Attenuated or Inactivated Lumpy Skin Disease Virus Vaccine
observed after a viral LSDV challenge in any of the vaccinated animals. A good immune response and protection were similarly seen for the LSDV Inac after 6 months. However, two animals developed clinical ...
Effect of neuraminidase inhibitor (oseltamivir) treatment on outcome of hospitalised influenza patients, surveillance data from 11 EU countries, 2010 to 2020.
sex, outcome, ward, vaccination status, timing of antiviral treatment, and hospitalisation were obtained. A mixed effect logistic regression model using country as random intercept was applied to ...
Safety and immunogenicity of a reduced dose of the BNT162b2 mRNA COVID-19 vaccine (REDU-VAC): A single blind, randomized, non-inferiority trial
I Desombere; Kevin K. Ariën; Maria Goossens Source: PLOS Global Public Health, Volume 2, Issue 12 (2022) Keywords: COVID-19; fractional dose; reduced dose; mRNA vaccination; non-inferiority; SARS-CoV-2 Abstract: ...